QLT (QLTI)

Company

"QLT Inc. is a global biopharmaceutical company specializing in developing treatments for eye diseases as well as dermatological and urological conditions. Together with our subsidiaries, we have combined our expertise in the discovery, development and commercialization of innovative drug therapies with our two unique technology platforms, photodynamic therapy and Atrigel®, to create products such as Visudyne® and Eligard®." (company website)

Buy

20-Dec-06. QLT has just touched up with the 50-day moving average again. According to MarketEdge it is "oversold" and this is a "good entry point."

• Price momentum (PPO) — step drop-off during pullback
• Trend (ADX) — strengthening, although not yet over threshhold
• Money flow (CMF) — flowing in, barely
• Relative strength (RSI) — back down to neutral
• Volume — over 800K shares per day, average volume

Sell

29-Dec-06. Yesterday in a crise de confiance, I raised the activation price for my stop-loss order. This morning I went one stop further and sold QLTI. Although money flow (CMF) has stabilized, the trend (ADX) keeps strengthening, and the low intra-day prices seem to be following the lower Bollinger band down. Simply put, this is not encouraging. Out with the old, in with the new!